We are live on ! Find out more
KA

KLCM Advisors Portfolio holdings

AUM $1.19B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
-3.95%
1 Year Est. Return
+34.45%
3 Year Est. Return
+97.42%
5 Year Est. Return
+107.96%
10 Year Est. Return
+263.06%
AUM
$466M
AUM Growth
+$13.6M
Cap. Flow
+$33.4M
Cap. Flow %
7.17%
Top 10 Hldgs %
46.05%
Holding
122
New
11
Increased
41
Reduced
30
Closed
3

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$9.99M
2
OGN icon
Organon & Co
OGN
+$796K
3
ORCL icon
Oracle
ORCL
+$539K
4
CTRA
Coterra Energy
CTRA
+$447K
5
BA icon
Boeing
BA
+$363K

Sector Composition

Rank Sector Weight
1 Industrials 17.02%
2 Technology 16.84%
3 Healthcare 15.7%
4 Financials 14.98%
5 Communication Services 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNC icon
101
Lincoln National
LNC
$8.73B
$224K 0.05%
3,256
EXC icon
102
Exelon
EXC
$47.2B
$220K 0.05%
+6,378
New +$218K
PTEN icon
103
Patterson-UTI
PTEN
$3.98B
$220K 0.05%
24,500
JCI icon
104
Johnson Controls International
JCI
$88.8B
$217K 0.05%
3,190
DD icon
105
DuPont de Nemours
DD
$18.5B
$212K 0.05%
2,487
+5
+0.2% +$463
CI icon
106
Cigna
CI
$73.7B
$205K 0.04%
1,026
HD icon
107
Home Depot
HD
$331B
$204K 0.04%
+620
New +$204K
HTLF
108
DELISTED
Heartland Financial USA, Inc.
HTLF
$203K 0.04%
+4,216
New +$196K
VUZI icon
109
Vuzix
VUZI
$194M
$150K 0.03%
14,320
TELL
110
DELISTED
Tellurian Inc.
TELL
$78K 0.02%
20,000
+10,000
+100% +$34.2K
NOK icon
111
Nokia
NOK
$51B
$69K 0.01%
12,726
+2,000
+19% +$11.6K
OPK icon
112
Opko Health
OPK
$985M
$36K 0.01%
10,000
-10,000
-50% -$37.2K
AXP icon
113
American Express
AXP
$227B
-1,395
Closed -$230K
LRCX icon
114
Lam Research
LRCX
$367B
-3,170
Closed -$206K
OGN icon
115
Organon & Co
OGN
$3.56B
-26,297
Closed -$796K

Similar funds

KLCM Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, KLCM Advisors held 122 positions worth $466M, up 3% from $452M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

KLCM Advisors deployed $33.4M of net new capital in Q3 2021, opening 11 new positions and adding to 41 existing holdings. Its largest new stake was Flowserve: 191,320 shares worth $6.63M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $9.99M trimmed.

  • KLCM Advisors's largest Q3 2021 buy was Flowserve: 191,320 shares worth $6.63M.
  • KLCM Advisors added most to AT&T in Q3 2021, an estimated $7.16M increase.
  • KLCM Advisors's biggest Q3 2021 reduction was Pfizer, cutting an estimated $9.99M.
  • KLCM Advisors fully exited Organon & Co in Q3 2021, selling an estimated $796K.
  • KLCM Advisors's ten largest holdings make up 46% of its $466M portfolio in Q3 2021.
  • KLCM Advisors opened 11 new positions and closed 3 in Q3 2021.
  • KLCM Advisors's portfolio value rose 3% quarter-over-quarter to $466M.

Based on KLCM Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.